The US Food and Drug Administration (FDA) has granted accelerated approval to Verastem Oncology’s oral combination therapy ...

Johnson & Johnson (J&J) and Protagonist Therapeutics’ investigational oral peptide icotrokinra (JNJ-2113) has been associated ...

The phase 3 GLISTEN trial has been evaluating the candidate in adults with PBC and cholestatic pruritus, or relentless itch, ...

Changes in the healthcare world are likely to limit opportunities for young researchers, especially women.Three leaders in ...

Gene therapy has the potential to change lives, slowing or stopping disease progression or even correcting symptoms entirely, ...

The US Food and Drug Administration (FDA) has announced that all its centres will operate on a common generative artificial ...

BeiGene has announced that its Tevimbra (tislelizumab) has been approved by the European Commission (EC) as part of a ...

Inizio Evoke has appointed Tristen George and Kevin Kaniuga as executive creative directors in a move aimed at “further strengthening” the agency’s creative leadership. George and Kaniuga both hold ...

Private equity firm Apiary Capital has completed its investment into life sciences performance marketing and specialist ...